This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Radionics, Inc.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Innovations in Radiation Dosimetry by Zachary H Leber
Introduction
Zachary H Leber is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of radiation dosimetry, particularly through his innovative patent that enhances treatment planning for patients undergoing radiation therapy.
Latest Patents
Zachary holds a patent for "Automatic planning for radiation dosimetry." This invention focuses on the automatic determination of beam parameters and other criteria necessary for creating a dose plan of radiation directed at a target volume. The method involves assessing geometric and other radiation involvement criteria, allowing for a comprehensive search of the phase space concerning the incoming direction of irradiation beam ports. By evaluating the goodness of fit based on parameter thresholds and other considerations, this invention improves treatment planning dosimetry. It is applicable to both circular and non-circular collimator shapes and can be illustrated using a linear accelerator (LINAC) for X-ray delivery to target volumes, such as tumors within a patient's body.
Career Highlights
Zachary H Leber has made a notable impact in the field of medical technology through his work at Radionics, Inc. His expertise in radiation dosimetry has positioned him as a key figure in advancing treatment methodologies for cancer patients.
Collaborations
Zachary has collaborated with esteemed colleagues, including Hanne M Kooy and Hsiao-Ming Lu, to further enhance the effectiveness of his innovations in radiation therapy.
Conclusion
Zachary H Leber's contributions to radiation dosimetry through his innovative patent demonstrate his commitment to improving patient care in oncology. His work continues to influence the field and offers promising advancements in treatment planning.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile